Similar to semaglutide which is also used for weight management, it operates on GLP-1 receptors, but it ALSO targets an additional receptor called GIP, making it a super-drug with demonstrated superior weight loss and glucose control
Clinical trials evaluating safety, effectiveness, and long-term outcomes are also based on a weekly dosing schedule
The post hoc analysis, which included the four SURMOUNT trials [1], compared tirzepatide with a placebo for up to 72 to 88 weeks in 4,677 adults (2,999 females, 1,678 males) living with obesity, highlighting potential sex differences in the response
Per-Batch HPLC + Copper Content Verification Because GHK-Cu activity depends on intact copper coordination, every lot is screened both by HPLC for peptide purity and by ICP-based analysis for copper content